Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.48801 | 19 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.47358 | 20 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.46529 | 19 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.44209 | 21 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.43255 | 20 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.52984 | 20 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.46885 | 18 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.46624 | 20 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.46267 | 21 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.46487 | 20 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.45979 | 20 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.46419 | 21 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.46757 | 20 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.46835 | 20 |